Igm Biosciences, INC.

Based in CA

🤖

AI Overview

With $2.0M in lobbying spend across 14 quarterly filings, Igm Biosciences, INC is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2021 to 2024.

$2.0M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2021	$140K
2022	$660K
2023	$930K
2024	$250K

Issues Lobbied

MED

Lobbying Firms

Igm Biosciences, INC.

Lobbyists

Andrew Womack

Government Agencies Targeted

These are the government entities that Igm Biosciences, INC. disclosed contacting in their lobbying filings.

Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESSENATEExecutive Office of the President (EOP)

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED

Issues relating to the development of antibody therapy for COVID-19

Issues relating to the development of antibody therapy for COVID-19.

Issues related to supply chain and biopharmaceutical manufacturing.

H.R.2471 - Consolidated Appropriations Act, 2022 COVID Supplemental Appropriation FY2023 Defense Appropriations S.2076/H.R.3932 - PASTEUR Act of 2021 S.3799 - PREVENT Pandemics Act Issues related to t

COVID Supplemental Appropriation FY2023 Defense Appropriations S.2076/H.R.3932 - PASTEUR Act of 2021 S.3799 - PREVENT Pandemics Act Issues related to the development of an antibody therapy for COVID-1